Search

Search bills, members, committees and pages...

THE CAMPAIGN FOR SUSTAINABLE RX PRICING

14 federal lobbying filings, 2023 to 2026.

THE CAMPAIGN FOR SUSTAINABLE RX PRICING is a client on 14 federal lobbying filings, 2023 to 2026, reporting $970K across them. A coalition of organizations working on market-based solutions to drug pricing. Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
MEHLMAN CONSULTING, INC.14$970K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$180K
20254$360K
20244$230K
20234$200K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
CPTCopyright/Patent/Trademark14
MMMMedicare/Medicaid14
PHAPharmacy14
TAXTaxation/Internal Revenue Code2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.6
S. 1040Drug Competition Enhancement Act6
S. 1041Affordable Prescriptions for Patients Act6
S. 1095Stop STALLING Act6
S. 1096Preserve Access to Affordable Generics and Biosimilars Act6
S. 1097Interagency Patent Coordination and Improvement Act of 20256
S. 229DTC Act of 20256
S. 43Skinny Labels, Big Savings Act6
H.R. 3269ETHIC Act5
H.R. 3789DTC Act of 20255
S. 1954Biosimilar Red Tape Elimination Act5
S. 2276ETHIC Act5
H.R. 3010No Handouts for Drug Advertisements Act4
H.R. 3152Patent Eligibility Restoration Act of 20254
H.R. 3160PREVAIL Act4
S. 1032Major Richard Star Act4
S. 1533A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contr…4
S. 1546Patent Eligibility Restoration Act of 20254
S. 1785No Handouts for Drug Advertisements Act4
S. 2630Saving NSF’s Workforce Act4
H.R. 1262Mikaela Naylon Give Kids a Chance Act3
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.2
H.R. 4570Interagency Patent Coordination and Improvement Act of 20252
H.R. 5526Biosimilar Red Tape Elimination Act2
H.R. 6485Skinny Labels, Big Savings Act2

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2026 second_quarter$90KJul 20, 2026
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2026 first_quarter$90KApr 17, 2026
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2025 fourth_quarter$90KJan 16, 2026
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2025 third_quarter$90KOct 17, 2025
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2025 second_quarter$90KJul 21, 2025
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2025 first_quarter$90KApr 17, 2025
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2024 fourth_quarter$80KJan 21, 2025
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2024 third_quarter$50KOct 18, 2024
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2024 second_quarter$50KJul 18, 2024
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2024 first_quarter$50KApr 19, 2024
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2023 fourth_quarter$50KJan 19, 2024
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2023 third_quarter$50KOct 19, 2023
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2023 second_quarter$50KJul 18, 2023
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.2023 first_quarter$50KApr 19, 2023